NCT00380120View on ClinicalTrials.gov

Ultrasound Findings to Adjust the Duration of Anticoagulation

PHASE3CompletedINTERVENTIONAL
Enrollment

538

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2006

Conditions
Deep Vein Thrombosis
Interventions
DRUG

sodium warfarin

dosage: as much as it is required to prolong the international normalized ratio, checked every 2-3 weeks, between 2.0 and 3.0

DRUG

Sodium warfarin

As much drug as it is necessary to prolong the international normalized ratio between 2.0 and 3.0

Trial Locations (1)

35128

Department of Medical and Surgical Sciences, 2nd Chair of Internal Medicine, University of Padua, Padua

All Listed Sponsors
lead

University of Padova

OTHER

NCT00380120 - Ultrasound Findings to Adjust the Duration of Anticoagulation | Biotech Hunter | Biotech Hunter